Valiltramiprosate
Tier C — Watch / tradeValiltramiprosate
Targets：GABAAR, APP
Indications (approved)：Alzheimer's disease
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| - | - | - |
| - | 13734-41-3 | (tert-butoxycarbonyl)-L-valine |
| - | 738548-77-1 | 2,5-dioxopyrrolidin-1-yl L-valinate |
| - | 3687-18-1 | 3-aminopropane-1-sulfonic acid |
Frequently asked questions
What are the approved indications of Valiltramiprosate?
Approved indications include: Alzheimer's disease.
When does the Valiltramiprosate patent expire?
No public expiry year is available for Valiltramiprosate yet; this page updates once verified.
How many synthesis routes are recorded for Valiltramiprosate?
1 synthesis routes are recorded; the shortest is 2 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Valiltramiprosate intermediates?
All intermediates in Valiltramiprosate routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Valiltramiprosate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21